Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement

• Post author:GHIAA Admin
• Post published:August 12, 2022
• Post category:

Continue ReadingGates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement

Gates Foundation – Arsanis, S. Aureus Antibody Strategic Relationship Letter Agreement

• Post author:GHIAA Admin
• Post published:April 26, 2022
• Post category:

Continue ReadingGates Foundation – Arsanis, S. Aureus Antibody Strategic Relationship Letter Agreement

Gates Foundation – Arsanis RSV Monoclonal Antibodies Funding Agreement

• Post author:GHIAA Admin
• Post published:April 25, 2022
• Post category:

Continue ReadingGates Foundation – Arsanis RSV Monoclonal Antibodies Funding Agreement

Ocugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement

• Post author:GHIAA Admin
• Post published:January 3, 2022
• Post category:

Continue ReadingOcugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement

Moderna – Lonza, COVID-19 mRNA Vaccine & Therapies, Manufacturing & Process Development Agreement

• Post author:GHIAA Admin
• Post published:November 18, 2021
• Post category:

Continue ReadingModerna – Lonza, COVID-19 mRNA Vaccine & Therapies, Manufacturing & Process Development Agreement

Novavax – Serum Institute of India, COVID-19 Vaccine Supply and License Agreement

• Post author:GHIAA Admin
• Post published:September 10, 2021
• Post category:

Continue ReadingNovavax – Serum Institute of India, COVID-19 Vaccine Supply and License Agreement

Gates Foundation Sample Grant Terms & Conditions

• Post author:GHIAA Editor
• Post published:May 22, 2020
• Post category:

Continue ReadingGates Foundation Sample Grant Terms & Conditions